Cancer News and Research

Latest Cancer News and Research

Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression

Prozac works wonders for some depressed people, but not for others. In some cases, patients derive little benefit and at worst, it can lead to bizarre hallucinations and fits of rage. Researchers and doctors remain puzzled as to what causes the wide range of reaction to Prozac and similar antidepressants.

28 Oct 2009

UCSF receives $6.5 million gift from philanthropists Irwin and Joan Jacobs of La Jolla

Philanthropists Irwin and Joan Jacobs of La Jolla, CA are giving a $6.5 million gift to UCSF for head and neck cancer research. It is believed to be the largest private, U.S. gift for research supporting this disease.

28 Oct 2009

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, according to a study in the October 28 issue of JAMA.

28 Oct 2009

St. Jude Children's Research Hospital named among the top 10 "Best Places to Work in Academia"

St. Jude Children's Research Hospital has been listed among the top 10 "Best Places to Work in Academia" by The Scientist magazine -- this year's seventh place ranking is the fourth straight year the institution has placed in the top 10.

27 Oct 2009

Medicines used for lowering blood cholesterol may be effective in the treatment of cancer

Millions of people around the world use medicines based on statins to lower their blood cholesterol, but new research from the University of Gothenburg, published in the prestigious journal PNAS, shows that statins may also be effective in the treatment of cancer.

27 Oct 2009

Roche's high-throughput sequencing technology used for high-resolution HLA genotyping

A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences, a Roche Company, to carry out high-resolution human leukocyte antigen (HLA) genotyping in research samples.

27 Oct 2009

URI scientists discover a new and effective approach for treating cancerous tumor

Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects.

27 Oct 2009

Consumer health informatics applications help patients to better manage their health care

Electronic tools and technology applications for consumers can help improve health care processes, such as adherence to medication and clinical outcomes like smoking cessation, according to a report by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Oct 2009

GE’s AgileTrac Asset Manager and Enterprise Capacity Management Solution adopted by Virtua Healthcare

Virtua and GE Healthcare announced today that they are collaborating to implement new solutions to help increase efficiencies, lower healthcare costs and improve patient care throughout the health system. Virtua is adopting GE’s AgileTracTM Asset Manager and Enterprise Capacity Management Solution, an automated workflow solution that allows healthcare staff to better track a patient’s inpatient experience, as well as manage the hospital’s assets, ultimately reducing costs and increasing patient satisfaction.

27 Oct 2009

Combination of treatments for breast cancer

At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J. Barth Jr., M.D., and three fellow researchers are making the case for a particular combination of treatments to stop the tumors in their tracks.

27 Oct 2009

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university's Department of Biomedical Engineering.

27 Oct 2009

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Regional Medical Center Anniston has selected its ProVation® MD software for Cardiology procedure documentation and coding. The Anniston, AL-based hospital will use the software to document and code cases at its three cardiac catheterization labs.

27 Oct 2009

Amorfix Life Sciences detects prions in blood from non-human primates that were orally-infected with BSE

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today it has detected prions in blood from non-human primates that were orally-infected with BSE and developed a primate version of vCJD.

27 Oct 2009

NeoPharma submits a Phase II protocol to the FDA for its liposome entrapped docetaxel study

NeoPharm, Inc. today announced that it has submitted a Phase II protocol to the FDA for the study of liposome entrapped docetaxel (LE-DT), a novel, proprietary liposomal delivery system of docetaxel, the active ingredient of Taxotere®, for locally advanced or metastatic pancreatic cancer patients.

27 Oct 2009

Oncolytics Biotech receives its 33rd U.S. Patent

Oncolytics Biotech Inc. today announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone.

27 Oct 2009

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial

Celsion Corporation and Yakult Honsha Co., Ltd. announced today that the first patient has been enrolled and treated in Japan as part of Celsion’s global Phase III ThermoDox HEAT trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer.

27 Oct 2009

Hope for lung cancer patients

Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year. It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.

27 Oct 2009

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company’s dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).

27 Oct 2009

BioSphere submits an IDE to the FDA for its QuadraSphere Microsphere product

BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere’s QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.

27 Oct 2009

Champions Biotechnology obtains global rights to Tel Aviv University's TAR-1 compound

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.

27 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression

UCSF receives $6.5 million gift from philanthropists Irwin and Joan Jacobs of La Jolla

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

St. Jude Children's Research Hospital named among the top 10 "Best Places to Work in Academia"

Medicines used for lowering blood cholesterol may be effective in the treatment of cancer

Roche's high-throughput sequencing technology used for high-resolution HLA genotyping

URI scientists discover a new and effective approach for treating cancerous tumor

Consumer health informatics applications help patients to better manage their health care

GE’s AgileTrac Asset Manager and Enterprise Capacity Management Solution adopted by Virtua Healthcare

Combination of treatments for breast cancer

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Amorfix Life Sciences detects prions in blood from non-human primates that were orally-infected with BSE

NeoPharma submits a Phase II protocol to the FDA for its liposome entrapped docetaxel study

Oncolytics Biotech receives its 33rd U.S. Patent

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial

Hope for lung cancer patients

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

BioSphere submits an IDE to the FDA for its QuadraSphere Microsphere product

Champions Biotechnology obtains global rights to Tel Aviv University's TAR-1 compound

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in